0 Σχόλια
0 Μοιράστηκε
206 Views
0 Προεπισκόπηση
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
From Conventional to Targeted: Tracing the Pivotal Shift in Soft Tissue Sarcoma Treatment Modalities and Drug Pipeline DynamicsHistorically, the treatment paradigm for soft tissue sarcoma (STS) relied heavily on a combination of surgical resection, radiation therapy, and cytotoxic chemotherapy, the latter often serving as the primary systemic treatment for advanced or metastatic disease. While chemotherapy drugs like doxorubicin and ifosfamide remain foundational, their non-specific mechanism of action often leads to...0 Σχόλια 0 Μοιράστηκε 314 Views 0 Προεπισκόπηση
-
Quantifying Market Size by Drug Volume and Revenue: The Commercial Valuation of Acid Suppressants in the Germany Gastritis Treatment MarketQuantifying the market Size of the Germany Gastritis Treatment Market involves assessing the massive procedural and prescription volume generated by the core drug classes, primarily Proton Pump Inhibitors (PPIs). The total market Size is directly correlated with the high prevalence of gastritis and ulcer disease in the general German population, a figure that is consistently translated...0 Σχόλια 0 Μοιράστηκε 200 Views 0 Προεπισκόπηση
-
Amitriptyline Market: Projected to Hit $1.01 Billion by 2032Introspective Market Research (IMR) today released its comprehensive report on the Global Amitriptyline Market. According to the analysis, the market was valued at USD 609.2 million in 2023 and is projected to reach USD 1,011.9 million by 2032, growing at a compound annual growth rate (CAGR) of 5.8% from 2024 to 2032. This growth is largely underpinned by the expanding burden of depression and...0 Σχόλια 0 Μοιράστηκε 547 Views 0 Προεπισκόπηση
-
ANTIPSYCHOTIC DRUGS MARKET: Global Value Set to Double, Reaching $33.91 Billion by 2032Introspective Market Research (IMR) today published a new report on the Global Antipsychotic Drugs Market, forecasting it to grow from USD 17.48 billion in 2023 to USD 33.91 billion by 2032, at a compound annual growth rate (CAGR) of 7.63% over the 2024–2032 period. This expansion is largely driven by increasing global incidence of psychiatric disorders such as schizophrenia and bipolar...0 Σχόλια 0 Μοιράστηκε 394 Views 0 Προεπισκόπηση
-
Onychomycosis Treatment Market - Share Analysis (2024–2032)Introspective Market Research (IMR) announces the publication of its latest in-depth analysis of the Global Onychomycosis Treatment Market. Onychomycosis, a common fungal infection affecting fingernails and toenails, is demanding increasingly sophisticated and rapid treatment modalities. The market, which was valued at USD 3.5 Billion in 2023, is projected to grow to USD 5.2 Billion by 2032,...0 Σχόλια 0 Μοιράστηκε 221 Views 0 Προεπισκόπηση
-
Orthopaedic Devices MarketIntrospective Market Research (IMR) has released a definitive analysis of the Global Orthopaedic Devices Market, revealing a landscape rapidly being reshaped by digital surgery and patient-specific implant design. The market, valued at USD 60.5 Billion in 2023, is forecast to achieve a valuation of USD 89.14 Billion by the end of 2032, reflecting a robust Compound Annual Growth Rate (CAGR) of...0 Σχόλια 0 Μοιράστηκε 296 Views 0 Προεπισκόπηση
-
Osteoarthritis Drugs MarketIntrospective Market Research (IMR) today unveiled a critical new report detailing the accelerated evolution of the Global Osteoarthritis (OA) Drugs Market. The market, valued at USD 4.70 Billion in 2023, is forecast to more than double, reaching USD 10.38 Billion by 2032, demonstrating a high-velocity Compound Annual Growth Rate (CAGR) of 9.2% during the 2024–2032 forecast period. This...0 Σχόλια 0 Μοιράστηκε 261 Views 0 Προεπισκόπηση
-
Respiratory Tract Infection Treatment Market - Share Analysis (2024–2032)Introspective Market Research (IMR) has released a critical analysis of the Global Respiratory Tract Infection (RTI) Treatment Market, highlighting its rapid expansion fueled by persistent global health challenges. RTIs, including pneumonia, bronchitis, and sinusitis, remain a leading cause of morbidity and mortality worldwide. The market, which was valued at USD 40.20 Billion in 2023, is...0 Σχόλια 0 Μοιράστηκε 302 Views 0 Προεπισκόπηση